Patents by Inventor John Fraser

John Fraser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10465476
    Abstract: A downhole support device for use in a wellbore is provided, where the device (200) is adapted to be run into the wellbore (202) through or on a workstring (204). The device (200) comprises an inflatable element (206) adapted to be selectively connectable to the workstring (204). The inflatable element (206) selectively applies a biasing force to an external structure such, for example, a wall (214) of the wellbore (202) when in an inflated state. The inflatable element (206) has an inlet (208) for receiving and being inflated by a flowing substance. The device (200) also comprises an inflation mechanism (210) and a disconnect mechanism (222) adapted to be selectively disconnectable from the workstring (204). A method of deploying a barrier in a wellbore which makes use of the support device is also provided.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: November 5, 2019
    Assignee: Coretrax Technology Limited
    Inventors: John Kenneth Fraser Murray, John Fraser, Jason Fong
  • Publication number: 20190321463
    Abstract: Methods for preparing highly purified AAV vector formulations are provided. The highly pure AAV formulations described herein are superior for clinical use.
    Type: Application
    Filed: May 23, 2019
    Publication date: October 24, 2019
    Applicant: The Children's Hospital of Philadelphia
    Inventors: John Fraser Wright, Guang Qu, Bernd Hauck, Katherine A. High
  • Publication number: 20190292561
    Abstract: Methods and compositions for transfecting cells with plasmids are disclosed. In certain embodiments, methods and compositions are disclosed in which transfection efficiency is significantly increased by contacting the cells being transduced with polyethyleneimine (PEI) that is free of nucleic acid during the transfection process. Therapeutically useful adeno-associated viral vectors generated according to the disclosed methods and compositions are also disclosed.
    Type: Application
    Filed: December 1, 2016
    Publication date: September 26, 2019
    Applicant: SPARK THERAPEUTICS, INC.
    Inventors: Guang QU, Lin LU, John Fraser WRIGHT
  • Publication number: 20190284576
    Abstract: Provided are methods for producing recombinant adeno-associated virus (rAAV) vector particles at high recovery or high titer. Also provided are methods that concentrate rAAV vectors to a high concentration, for example, up to 5E+13 (5×1013) vector genomes per milliliter (Vg/ml) with little if any rAAV aggregates.
    Type: Application
    Filed: July 21, 2017
    Publication date: September 19, 2019
    Applicant: SPARK THERAPEUTICS, INC.
    Inventors: Guang QU, John Fraser WRIGHT, Younghoon OH, Yuhuan WANG, Haibo ZHANG, Laura DUNCAN
  • Publication number: 20190277113
    Abstract: A deformable cleaning element is encased within soluble packaging to maintain deformation. The deformed cleaning element is launched into the bore of a drill pipe/conduit or tubular. Contact with fluids within the bore dissolves the soluble packaging allowing the cleaning element to expand to its original shape.
    Type: Application
    Filed: May 24, 2019
    Publication date: September 12, 2019
    Applicant: CORETRAX TECHNOLOGY LIMITED
    Inventors: John Fraser, Cherish Bodman, Jason Fong
  • Patent number: 10390642
    Abstract: A holder and display device includes three rectangular rigid panels, and a knife receiving structure formed on an inner surface of one of the rigid panels. A flexible sheet is attached to each of the rigid panels such that the flexible sheet hingably connects the rigid panels together, whereby the three panels may hinge with respect to each other via the flexible sheet between a closed configuration and a display configuration.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: August 27, 2019
    Inventor: Matthew John Fraser
  • Patent number: 10392632
    Abstract: This application relates to the fields of gene therapy and molecular biology. In accordance with the present invention, an adeno-associated virus (AAV) vector comprising an altered capsid protein is provided. More specifically, this invention provides adeno-associated viral vectors comprising protein capsid variants which accelerate vector breakdown and clearance, thereby reducing undesirable immune responses.
    Type: Grant
    Filed: February 14, 2012
    Date of Patent: August 27, 2019
    Assignee: THE CHILDREN'S HOSPITAL OF PHILADELPHIA
    Inventors: John Fraser Wright, Olga Zelenaia, Bernd Hauck, Federico Mingozzi, Katherine A. High
  • Publication number: 20190247439
    Abstract: Provided herein are methods and compositions for the treatment of musculoskeletal disorders, including disorders of a joint.
    Type: Application
    Filed: October 7, 2016
    Publication date: August 15, 2019
    Inventors: Steven Kesten, Marc Hedrick, John Fraser
  • Patent number: 10344566
    Abstract: A deformable cleaning element is encased within soluble packaging to maintain deformation. The deformed cleaning element is launched into the bore of a drill pipe/conduit or tubular. Contact with fluids within the bore dissolves the soluble packaging allowing the cleaning element to expand to its original shape.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: July 9, 2019
    Assignee: Coretrax Technology Limited
    Inventors: John Fraser, Cherish Bodman, Jason Fong
  • Patent number: 10328145
    Abstract: Methods for preparing highly purified AAV vector formulations are provided. The highly pure AAV formulations described herein are superior for clinical use.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: June 25, 2019
    Assignee: The Children's Hospital of Philadelphia
    Inventors: John Fraser Wright, Guang Qu, Bernd Hauck, Katherine A. High
  • Publication number: 20190093126
    Abstract: In accordance with the present invention, a method for increasing the yield of rLV vector particles comprising a trans gene encoding a therapeutic protein or fragment thereof is disclosed. In one approach, cells are transfected with plasmids encoding the necessary components for rLV production using a calcium chloride transfection mix at pH 7.1 wherein the calcium chloride and plasmids form a complex which is added to the cells at a constant speed. The cells are then incubated for a suitable time period wherein virus particle media is collected at least twice during the incubation period and stored in a cold storage unit, thereby reducing virus inactivation.
    Type: Application
    Filed: August 27, 2018
    Publication date: March 28, 2019
    Applicant: The Children's Hospital of Philadelphia
    Inventors: Katherine A. High, John Fraser Wright, Bernd Hauck, Guang Qu
  • Publication number: 20190078099
    Abstract: Cells and cell lines are disclosed that are able to produce therapeutic proteins, antibodies, vectors, and viral vectors such as lentiviral vectors and adeno-associated viral (AAV) vectors. The cells and/or cell lines can have mutations or deletions in either one or both of the endogenous di-hydrofolate reductase (DHFR?/?) or glutamine synthetase (GS?/?) genes such that DHFR and/or GS expression or function is substantially reduced or eliminated.
    Type: Application
    Filed: March 30, 2017
    Publication date: March 14, 2019
    Applicant: SPARK THERAPEUTICS, INC.
    Inventors: Jingmin ZHOU, Guang QU, John Fraser WRIGHT
  • Publication number: 20190032081
    Abstract: Methods for separating AAV empty capsids from mixtures of AAV vector particles and AAV empty capsids are described. The methods use column chromatography techniques and provide for commercially viable levels of recombinant AAV virions.
    Type: Application
    Filed: June 26, 2018
    Publication date: January 31, 2019
    Inventors: Guang QU, John Fraser WRIGHT
  • Publication number: 20180139882
    Abstract: A new cultivar of Cordyline plant named ‘Paso Doble’ that is characterized by leaves that are linear in shape, upright and dark red in color with dark pink margins.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 17, 2018
    Inventor: Peter John Fraser
  • Publication number: 20180135097
    Abstract: Methods for measuring REP-1 and REP-2 activity are provided. In certain embodiments, a method includes: (a) contacting cells that do not express endogenous functional REP-1 or REP-2 protein with an adeno-associated viral (AAV) vector comprising a CHM gene encoding a REP-1 protein or CHM like gene encoding a REP-2 protein under conditions allowing cell transduction; (b) incubating transduced cells under conditions allowing expression of the encoded REP-1 or REP-2 protein; (c) lysing the transduced cells to produce an extract comprising the encoded REP-1 or REP-2 protein and Rab small GTPase (Rabs); (d) incubating said extract with a Rab substrate for a period of time and under conditions allowing prenylation of the Rab thereby forming prenylated Rab; and (e) detecting and/or quantifying the prenylated Rab, wherein the amount of prenylated Rab reflects REP-1 or REP-2 activity thereby measuring REP-1 or REP-2 activity.
    Type: Application
    Filed: November 7, 2017
    Publication date: May 17, 2018
    Applicant: Spark Therapeutics, Inc.
    Inventors: John Fraser WRIGHT, Marina SUMAROKA
  • Patent number: 9955722
    Abstract: A portable, dishwasher safe, dry herb water pipe body capable of connection to a plethora of different fluid vessels. It has a flexible polymer bidirectional flow connector that facilitates the flow of smoke from and into the water pipe body. This flow connector also frictionally engages the neck of a bottle, jar or can, thereby sealing the fluid vessel to the body of the water pipe, completing its functionality. Ice can be placed in the water pipe to further cool the incoming smoke charge for the user. After use, if a disposable fluid vessel and fluid were used, the water pipe body can be removed and no further storage or cleaning action is required. With the optional plug, the device can be used in a dry smoke mode or fluid can be added into the plug for a shortened version of a water pipe.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: May 1, 2018
    Inventors: Hari Mark Reyes, Phillip John Fraser
  • Patent number: 9925219
    Abstract: The invention provides multi-chamber encapsulated cell therapy cartridge devices that are capable of delivering biologically active molecules as well as methods of using these devices.
    Type: Grant
    Filed: September 10, 2014
    Date of Patent: March 27, 2018
    Assignee: Neurotech USA, Inc.
    Inventors: Konrad A. Kauper, John Fraser Mills, Megan Billings, Michael R. Rivera, Alline Monteiro Alcantara Lelis
  • Publication number: 20170368201
    Abstract: Methods for preparing highly purified rLV vector formulations at the scale needed to meet anticipated demand for human gene therapy are provided.
    Type: Application
    Filed: September 8, 2017
    Publication date: December 28, 2017
    Applicant: The Children's Hospital of Philadelphia
    Inventors: Guang QU, John Fraser WRIGHT
  • Patent number: PP29714
    Abstract: A new cultivar of Cordyline plant named ‘Paso Doble’ that is characterized by leaves that are linear in shape, upright and dark red in color with dark pink margins.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: September 25, 2018
    Inventor: Peter John Fraser
  • Patent number: D863066
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: October 15, 2019
    Inventor: Matthew John Fraser